Iris Sison
About Iris Sison
Iris Sison serves as the Director and Head of Clinical Operations at IGM Biosciences, a position she has held since 2019. She has a background in clinical trials, having previously worked at Genentech in various leadership roles.
Work at IGM Biosciences
Iris Sison has been serving as the Director and Head of Clinical Operations at IGM Biosciences since 2019. In this role, she oversees the planning and execution of clinical trials, ensuring that they meet regulatory standards and align with the company's strategic objectives. Her leadership contributes to the advancement of innovative therapies in the biopharmaceutical sector.
Previous Experience at Genentech
Prior to her current position, Iris Sison worked at Genentech, where she held two significant roles. From 2015 to 2017, she was a Global Clinical Trial Leader, managing various aspects of clinical trials. Following this, she advanced to the position of Senior Global Clinical Trial Leader from 2017 to 2019, where she continued to enhance her expertise in clinical operations and trial management.
Education and Expertise
Iris Sison earned a Bachelor of Science degree from the University of California, Davis. Her educational background provides a strong foundation for her work in clinical operations, equipping her with the necessary knowledge and skills to navigate the complexities of clinical research and development in the pharmaceutical industry.
Career Progression
Iris Sison's career has shown a clear trajectory in clinical operations within the biopharmaceutical field. Starting at Genentech, she gained valuable experience that led to her promotion to senior leadership roles. Her transition to IGM Biosciences marks a significant step in her career, where she continues to apply her extensive knowledge in clinical trial management.